Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PLG mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in decreased expression of PLG mRNA | decreases expression | 20406850
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PLG mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PLG protein | affects expression | 20106945
|
D000584 |
Amiloride |
Amiloride inhibits the reaction [PLAU protein results in increased degradation of PLG protein] | decreases reaction|increases degradation | 14644129
|
D015119 |
6-Aminocaproic Acid |
6-Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17482686
|
D015119 |
6-Aminocaproic Acid |
6-Aminocaproic Acid inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 17482686
|
D000638 |
Amiodarone |
Amiodarone affects the expression of PLG mRNA | affects expression | 19483382
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PLG mRNA | affects expression | 16483693
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased activity of PLG protein | decreases activity | 19781379
|
D001553 |
Benzbromarone |
Benzbromarone affects the expression of PLG mRNA | affects expression | 19483382
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PLG mRNA | decreases expression | 20106945
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of AMY2 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of AURKA mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2A1D mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL6 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCNA2 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCNB1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCNB2 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CDC20 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CHI3L3 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CTDSP2 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of DBP mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of EGR1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ELA1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ELA2A mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ELOVL6 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of GSTM3 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of KIF22 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of LPL mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of MARCO mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of NNMT mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of OSTA mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of PLK1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of PMF1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of PNLIPRP1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of PRSS2 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of PTTG1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of SAA1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of STMN1 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of TRY4 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of X99384 mRNA] | increases expression|increases reaction | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2L11 protein] | affects reaction|increases expression | 17482686
|
D002251 |
Carbon Tetrachloride |
PLG protein affects the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17482686
|
D002251 |
Carbon Tetrachloride |
PLG protein affects the reaction [Carbon Tetrachloride results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 17482686
|
D002251 |
Carbon Tetrachloride |
PLG protein affects the susceptibility to Carbon Tetrachloride | affects response to substance | 16006527
|
D002251 |
Carbon Tetrachloride |
PLG protein inhibits the reaction [Carbon Tetrachloride results in increased expression of VWF protein] | decreases reaction|increases expression | 14716496
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PLG mRNA | affects expression | 12734012
|
D002994 |
Clofibrate |
Clofibrate affects the expression of PLG mRNA | affects expression | 19483382
|
D003276 |
Contraceptives, Oral |
Contraceptives, Oral results in increased expression of PLG | increases expression | 15185533
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of PLG mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in decreased expression of PLG mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol binds to Norethindrone] which results in increased expression of PLG protein | affects binding|increases expression | 14561536
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased activity of PLG protein | affects cotreatment|increases activity | 11720199
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PLG protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PLG protein | affects cotreatment|increases expression | 15157790 12618251
|
D004997 |
Ethinyl Estradiol |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PLG protein | affects cotreatment|increases expression | 12618251
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PLG protein | increases expression | 17374706
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased activity of PLG protein | increases activity | 15318540
|
C442659 |
ethinyl estradiol-desogestrel combination |
ethinyl estradiol-desogestrel combination results in increased expression of PLG protein | increases expression | 12618251
|
D005001 |
Ethionine |
Ethionine affects the expression of PLG mRNA | affects expression | 19483382
|
D005227 |
Fatty Acids |
Fatty Acids results in decreased activity of PLG protein | decreases activity | 14724836
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased activity of PLG protein | affects cotreatment|increases activity | 11720199
|
C033273 |
Gestodene |
[Ethinyl Estradiol co-treated with Gestodene] results in increased expression of PLG protein | affects cotreatment|increases expression | 12618251
|
D007531 |
Isoflurophate |
Isoflurophate inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17482686
|
D007531 |
Isoflurophate |
Isoflurophate inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 17482686
|
D009640 |
Norethindrone |
[Ethinyl Estradiol binds to Norethindrone] which results in increased expression of PLG protein | affects binding|increases expression | 14561536
|
C017576 |
norgestimate |
[Ethinyl Estradiol co-treated with norgestimate] results in increased expression of PLG protein | affects cotreatment|increases expression | 12618251
|
D016912 |
Levonorgestrel |
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PLG protein | affects cotreatment|increases expression | 12618251 15157790
|
C516519 |
NuvaRing |
NuvaRing results in increased expression of PLG protein | increases expression | 15157790
|
D009853 |
Omeprazole |
Omeprazole affects the expression of PLG mRNA | affects expression | 19483382
|
D010100 |
Oxygen |
Oxygen deficiency promotes the reaction [PLAU protein results in increased activity of PLG protein] | increases activity|increases reaction | 12485432
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [PLG protein results in increased phosphorylation of MAPK1 protein] | decreases reaction|increases phosphorylation | 17482686
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [PLG protein results in increased phosphorylation of MAPK3 protein] | decreases reaction|increases phosphorylation | 17482686
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of PLG mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid affects the expression of PLG mRNA | affects expression | 19483382
|
D011441 |
Propylthiouracil |
Propylthiouracil affects the expression of PLG mRNA | affects expression | 19483382
|
D012406 |
Roxarsone |
Roxarsone results in decreased expression of PLG mRNA | decreases expression | 18414637
|
D012645 |
Selenomethionine |
Selenomethionine affects the expression of PLG mRNA | affects expression | 17222674
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of PLG mRNA | affects expression | 19590694
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of PLG mRNA | affects expression | 17450228
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PLG mRNA | decreases expression | 20106945
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of PLG mRNA | increases expression | 16917069
|
D013853 |
Thioacetamide |
Thioacetamide affects the expression of PLG mRNA | affects expression | 19483382
|
D014260 |
Triclosan |
Triclosan inhibits the reaction [TNF protein results in increased metabolism of PLG protein] | decreases reaction|increases metabolic processing | 19874453
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.47 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.18 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
11.03 | 17505938 |
MESH:D000152 |
Acne Vulgaris |
|
norgestimate |
11.03 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
8.06 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.06 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.24 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.24 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.24 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.24 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.43 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.63 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.63 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.31 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.51 | 17306315 16712894 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.62 | 11748828 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.67 | 20872349 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.70 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
3.47 | 18218290 20041841 18057881 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.09 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.43 | 15885639 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.58 | 16391483 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.62 | 19698954 18651412 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
58.71 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Benzbromarone |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Ethionine |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Omeprazole |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
58.71 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
58.71 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Thioacetamide |
58.71 | 19483382 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.40 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.52 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.91 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.91 | 12948864 16675129 17018787 14630087 19861407 17289903 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
1.91 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.91 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.98 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.08 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.41 | 3786805 16011737 15673190 16097048 15700767 18705752 16227642 16050911 15721981 16124888 10355542 16192424 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.50 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
18.47 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
18.47 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
18.47 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
18.47 | 16217749 15073043 11135700 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Benzbromarone |
18.47 | 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
18.47 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
18.47 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
18.47 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thioacetamide |
18.47 | 17997003 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.49 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.79 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.19 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.19 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
4.75 | 14644129 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.15 | 18850075 16120746 18670907 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
2.76 | 19225199 15710769 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.70 | 18974383 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
18.30 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
18.30 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
18.30 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
18.30 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
18.30 | 20056578 19524636 |
MESH:D002637 |
Chest Pain |
|
Omeprazole |
4.72 | 15447763 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.48 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thioacetamide |
8.48 | 18291259 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.99 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.99 | 16919318 17110522 16105132 15861022 11677210 17333356 17681005 |
MESH:D002779 |
Cholestasis |
|
Levonorgestrel |
16.99 | 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
16.99 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.94 | 15668235 15340226 12621046 8697196 16354765 |
MESH:D003092 |
Colitis |
|
Amiloride |
4.74 | 12065299 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.85 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.49 | 17141729 14669216 |
MESH:D000013 |
Congenital Abnormalities |
|
Triclosan |
8.49 | 19283420 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.82 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
2.34 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.34 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.65 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.65 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.74 | 15213294 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.24 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.57 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.09 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
16.74 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
16.74 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
16.74 | 15265979 18218290 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
16.74 | 10092053 17522070 6884620 15998439 7179309 7120509 15027814 16227642 19336974 9327722 11566570 4309450 3732212 7440962 10915739 3786805 16177239 15968718 19085960 2869522 21278145 6623471 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
16.74 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
16.74 | 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Thioacetamide |
16.74 | 12963478 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.48 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Omeprazole |
3.97 | 15991576 17151854 21218061 16613094 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
3.79 | 16707586 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.45 | 20016425 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.43 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.51 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.83 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.73 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.69 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.07 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.07 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.73 | 11564622 |
MESH:D005218 |
Fat Necrosis |
|
Thioacetamide |
5.33 | 16456712 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
37.38 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
37.38 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
37.38 | 17595544 16239168 12795759 61145 15959796 19224547 12631006 16045604 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
37.38 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
37.38 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
37.38 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
37.38 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
37.38 | 16917069 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.08 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
12.56 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
12.56 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.56 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.90 | 16904648 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.83 | 20016425 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.30 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.84 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.21 | 10696789 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
4.51 | 19703807 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.76 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.76 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.30 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.04 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.00 | 11000095 |
MESH:D006501 |
Hepatic Encephalopathy |
|
Thioacetamide |
4.23 | 17276928 15929193 18665440 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
8.28 | 19110552 19900420 |
MESH:D006505 |
Hepatitis |
|
Thioacetamide |
8.28 | 16456712 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
12.27 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.27 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.27 | 16120746 12621046 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.64 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.84 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.37 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.66 | 16354765 15340226 8697196 18606429 16959395 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.15 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
3.54 | 9751232 8137927 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.85 | 20558911 |
MESH:D006973 |
Hypertension |
|
Amiloride |
7.81 | 19344079 15174897 18524855 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.81 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.81 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.72 | 15338365 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
5.47 | 19822448 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.44 | 16945680 16569931 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
10.37 | 17991464 18020914 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
10.37 | 18031379 8137927 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.11 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.91 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.91 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
Triclosan |
9.91 | 20821571 |
MESH:D007249 |
Inflammation |
|
Amiloride |
7.49 | 17237260 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.49 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Triclosan |
7.49 | 9584910 20507366 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.36 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.36 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.05 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
8.75 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
8.75 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.75 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
15.21 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
15.21 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.21 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
15.21 | 15610895 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Omeprazole |
3.79 | 19248655 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.64 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.46 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
10.45 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
10.45 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.15 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.42 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
2.07 | 20471514 19850784 16467208 16968895 17050201 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
2.96 | 19225113 15336539 15213294 12679006 16891316 17869043 19035177 17217047 17649720 15622746 19642359 16330433 19075265 16112521 17107899 16331271 16823087 15748426 16966277 11468182 17712046 12018890 12712474 9834237 11161223 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.99 | 16882451 |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.60 | 19344079 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
3.24 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.60 | 16239168 17334410 16221502 17157831 11408273 11903743 21278145 16943688 17174718 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
therapeutic |
|
| 14716496 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
6.14 | 16097048 18279442 20821823 16027843 16015684 15996030 18054572 15959796 16033810 18429990 14512876 15362042 15730626 12632512 17922224 18156304 18166357 17976157 12389079 18263696 17823541 14716833 17900296 18317297 14620537 17761835 12666154 18418968 15673190 16011737 17805973 17708605 12898905 17525996 16638106 17631135 17557913 18187930 18472332 17640975 18277467 12445421 17869086 12741479 15338365 12958196 18472094 12609069 12546737 18339082 12445418 18395095 17481882 18420326 14716496 12667390 18006644 18205269 15370692 13678700 17698563 15818738 14724832 18376398 16136751 16116963 12649538 15052691 14748882 15876570 15931870 15123356 12632514 17565644 18705752 17766677 18210741 18251166 18395914 15650968 18481824 16192424 18412020 10355542 15057751 17714472 15925388 17721639 17944888 15893842 16248980 12586293 11481614 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.14 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.14 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.14 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thioacetamide |
6.14 | 18263696 18295389 12679928 16248980 18615449 16126171 16343077 18031379 12085344 17050028 15288473 18032466 12557150 15474484 18606216 15316131 16511523 12531686 17127702 15078482 12891558 17629604 18395095 15716488 15465738 15095483 16098781 11682029 14739098 11481614 16489207 15288472 15362042 11172339 15334695 15075984 12175628 18458672 16097051 15158331 10677585 18416461 17355460 17292413 18380797 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.93 | 15720792 16246199 15830285 17285989 16964402 |
MESH:D008107 |
Liver Diseases |
|
Thioacetamide |
3.93 | 18374380 15158337 16337175 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.79 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
8.71 | 16899240 14706259 |
MESH:D017114 |
Liver Failure, Acute |
|
Thioacetamide |
8.71 | 15633222 15313186 12479984 17276928 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
23.22 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
23.22 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
23.22 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
23.22 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
23.22 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
23.22 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
23.22 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
23.22 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
16.08 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
16.08 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
16.08 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
16.08 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
16.08 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
7.23 | 11989578 15350150 17391786 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
7.23 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
6.66 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.66 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
4.09 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
4.14 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
6.00 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.00 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.00 | 17053015 20869020 20464547 18569708 18520028 18816296 20135361 20064080 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.00 | 17306315 17077188 16712894 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.00 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.74 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Triclosan |
5.74 | 15358634 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.09 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
1.98 | 19082730 16487513 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.40 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.90 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.84 | 19417148 15949261 14977855 19549372 11468182 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.14 | 16239165 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.51 | 17974566 12754197 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.28 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
2.92 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Contraceptives, Oral |
5.97 | 11752354 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.97 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.72 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.28 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.28 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.08 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.08 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
9.46 | 14644129 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
9.46 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.06 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.06 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.06 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.30 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.35 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.40 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.05 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.97 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.26 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.26 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.50 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.50 | 12854658 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
4.57 | 9802331 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.72 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.79 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.79 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Levonorgestrel |
4.43 | 12665316 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
7.12 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.12 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.12 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.39 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.34 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.81 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.86 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.04 | 11026799 |
OMIM:217090 |
PLASMINOGEN DEFICIENCY, TYPE I |
marker/mechanism |
|
| |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
ethinyl estradiol-desogestrel combination |
5.26 | 17105841 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.20 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.90 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.81 | 11118676 11222880 11896295 11399792 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.03 | 10903871 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.54 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.14 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.14 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.14 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.14 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
8.74 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Levonorgestrel |
8.74 | 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.09 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
2.70 | 12490602 11597910 12832656 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.20 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.16 | 18339021 17627322 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.47 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.60 | 16646077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.01 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.01 | 18551238 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.70 | 18724381 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.31 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.31 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.31 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.55 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.50 | 12854658 |
MESH:D013272 |
Stomach Diseases |
|
Omeprazole |
4.23 | 18545984 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.26 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.26 | 2093021 20155912 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
6.46 | 18087811 |
MESH:D013276 |
Stomach Ulcer |
|
Omeprazole |
6.46 | 16755016 17977527 10750652 11906479 18237397 15991576 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.16 | 12563064 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
3.93 | 11238279 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.83 | 19225199 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
16.44 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
ethinyl estradiol-desogestrel combination |
16.44 | 11994571 |
MESH:D019851 |
Thrombophilia |
|
Gestodene |
16.44 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
8.49 | 15669648 |
MESH:D013927 |
Thrombosis |
|
Gestodene |
8.49 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
18.92 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
18.92 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Triclosan |
18.92 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
6.49 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
6.49 | 15710170 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.49 | 18020914 19584973 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.30 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
8.99 | 17467628 11989578 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
8.99 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.09 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.09 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
14.09 | 20435036 12973940 11780464 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.09 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.09 | 11723127 16452187 16712894 17306315 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.72 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.72 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.44 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.94 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.60 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.04 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.21 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
15.96 | 15869587 14671159 |
MESH:D020246 |
Venous Thrombosis |
|
ethinyl estradiol-desogestrel combination |
15.96 | 15869587 |
MESH:D020246 |
Venous Thrombosis |
|
Levonorgestrel |
15.96 | 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.86 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.05 | 17120751 |